Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

August 17, 2017

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability

Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson’s Disease Clinical Trials: A Disease Progression Modeling Analysis

Conrado DJ, Nicholas T, Tsai K, Macha S, Sinha V, Stone J, Corrigan B, Bani M, Muglia P, Watson IA, Kern VD, Sheveleva E, Marek K,

Landscape analysis of biometric monitoring devices (BMDs) utilized in assessing cognition, sleep and mobility in Alzheimer’s disease and other age-related neurological diseases

Kern, V.D., et al.; “Landscape analysis of biometric monitoring devices (BMDs) utilized in assessing cognition, sleep and mobili

The Coalition Against Major Diseases: Towards U.S. FDA qualification of hippocampal volume as a biomarker for enrichment in clinical trials for pre-dementia stages of Alzheimer’s disease

Conrado, D.J., et al.; “The Coalition Against Major Diseases: Towards U.S. FDA qualification of hippocampal volume as a biomarke

April 7, 2017

Open Innovation: Towards Sharing of Data, Models and Workflows

D-RSC presents poster and talks about data standards at the Duchenne Connect Conference

D-RSC presents at the PPMD Connect Conference

C-Path and CDISC Announce Public Review Period for Duchenne Therapeutic Area Standard

June 13, 2017 TUCSON, Ariz., and AUSTIN, Texas – June 13, 2017 – The Clinical Data Interchange Standards Consort

Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy

The FDA is Listening: Integrating the Voice of the Patient in Drug Development for Parkinson’s and Huntington’s Diseases

Previous8182 83...125 Next